Bioterm Pharmaceuticals

Tel Aviv, Israel Founded: 2002 • Age: 24 yrs
Bioterm Pharmaceuticals develops drugs for treating and preventing pre-term labor and inducing labor.
Annual revenue $16.3M Latest available
Total funding - Funding intelligence
Employees 204 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Bioterm Pharmaceuticals

Bioterm Pharmaceuticals is a company based in Tel Aviv (Israel) founded in 2002. It operates as a B2B. The company has 204 employees as of March 31, 2023. Bioterm Pharmaceuticals operates in a competitive market with competitors including Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.

  • Headquarter Tel Aviv, Israel
  • Employees 204 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Jurisdiction East Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $16.28 M (USD)
    15.65
    as on Mar 31, 2023
  • Net Profit
    $2.39 M (USD)
    -6.4
    as on Mar 31, 2023
  • EBITDA
    $3.09 M (USD)
    -14.49
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    204

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Bioterm Pharmaceuticals

Premium access

Detailed funding history for Bioterm Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bioterm Pharmaceuticals

Investments
Premium access

Investment portfolio details for Bioterm Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Bioterm Pharmaceuticals

Premium access

Detailed financials for Bioterm Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bioterm Pharmaceuticals Comparisons

Bioterm Pharmaceuticals Primary company
Description
Bioterm Pharmaceuticals develops drugs for treating and prev...
Location
Tel Aviv, Israel
Founded Year
2002
Annual Revenue
$16.28 M (USD)
Net Profit
$2.39 M (USD)
EBITDA
$3.09 M (USD)
Employees
204
As of 2023
Premium access

Peer comparison for Bioterm Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Bioterm Pharmaceuticals

Bioterm Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapeutics for women's healthcare are developed and offered.
Locked Locked Locked
Developer of therapeutics and drug-device combinations for urology and sexual health
Locked Locked Locked
Developer of drugs for women's health and pain management
Locked Locked Locked
Microchip implants for wireless drug delivery are developed.
Locked Locked Locked
A proprietary oral testosterone replacement therapy platform is developed.
Locked Locked Locked
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
Premium access

Detailed competitors of Bioterm Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bioterm Pharmaceuticals

Premium access

Complete news archive for Bioterm Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bioterm Pharmaceuticals

Bioterm Pharmaceuticals was founded in 2002.

Bioterm Pharmaceuticals is headquartered in Tel Aviv, Israel.

As of Mar 31, 2023, the latest employee count at Bioterm Pharmaceuticals is 204.

Annual revenue of Bioterm Pharmaceuticals is $16.28M as on Mar 31, 2023.

Bioterm Pharmaceuticals bioterm pharmaceuticals develops drugs for treating and preventing pre-term labor and inducing labor, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and labor treatment. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Bioterm Pharmaceuticals's top competitors include Agile Therapeutics, Auxilium Pharmaceuticals and Marius Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available